Allegra Medical Technologies Limited

Equities

AMT

AU000000AMT8

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 12:10:21 2024-02-13 am EST			5-day change	1st Jan Change
0.029 ^AUD	+26.09%		-.--%	-35.56%

Mar. 22	Allegra Medical Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
Mar. 11	Trading in Allegra Medical Technologies' Stock Could Resume on March. 25	MT

Allegra Orthopaedics Limited Provides Earnings Guidance for the Full Year 2022

January 18, 2022 at 06:10 pm EST

Allegra Orthopaedics Limited provided earnings guidance for the full year 2022. For the period, the company's preliminary guidance of its Orthopaedic division, is revenues in the range of $3,200,000 to $3,500,000 and a net loss for the Orthopaedic division in the range of $700,000 to $1,000,000.

Latest news about Allegra Medical Technologies Limited

Allegra Medical Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 22	CI
Trading in Allegra Medical Technologies' Stock Could Resume on March. 25	Mar. 11	MT
Allegra Medical Technologies Pulls Out of FDA Submission for Spinal Cage Device	Feb. 06	MT
Allegra Orthopaedics Files Informal Response to US FDA Request for Spinal Cage Implant Application	Dec. 05	MT
Allegra Medical Technologies Completes Name Change	Nov. 01	MT
Allegra Orthopaedics Establishes Submission Timeline for US FDA Request on Spinal Cage Application	23-09-29	MT
Allegra Orthopaedics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Robinwood Investment Pty Limited completed the acquisition of All business assets of Orthopedics Division from Allegra Orthopaedics Limited.	23-08-27	CI
Robinwood Investment Pty Limited has entered into a binding agreement to acquire All business assets of Orthopedics Division from Allegra Orthopaedics Limited for AUD 4 million.	23-05-01	CI
Allegra Orthopaedics Files US FDA Submission for Implantable Spinal Cage Device	23-03-31	MT
Allegra Orthopaedics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Allegra Orthopaedics Completes Large Animal Study for Spinal Cage Project	23-02-21	MT
Allegra Orthopaedics Limited Announces Positive Results Upon Completion of the Large Animal Sheep Study	23-02-21	CI
Allegra Orthopaedics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-26	CI
Allegra Orthopaedics Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-24	CI
Allegra Orthopaedics Limited Announces Resignation of Anthony Hartnell as Director	22-02-07	CI
Allegra Orthopaedics Limited Announces Change of Company Secretary	22-02-04	CI
Allegra Orthopaedics Limited Announces Large Animal Study Shows Positive Results	22-01-30	CI
Allegra Orthopaedics Expects Surgery Restrictions to Impact Fiscal Year Earnings	22-01-19	MT
Allegra Orthopaedics Limited Provides Earnings Guidance for the Full Year 2022	22-01-18	CI
Allegra Orthopaedics Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-26	CI
Allegra Orthopaedics Limited Announces Improving Coating Techniques for Orthopaedic Implants	21-08-08	CI
Allegra Orthopaedics Limited announced that it expects to receive AUD 2 million in funding from Robinwood Investment Pty Limited	21-04-27	CI
Allegra Orthopaedics Limited Engages Robert Bell to Lead the Technology and Innovation Division	21-04-18	CI
Allegra Orthopaedics : Completes Pilot Animal Study for Spinal Cage Device	21-04-06	MT

Chart Allegra Medical Technologies Limited

Duration

Period

Chart Allegra Medical Technologies Limited

More charts

Company Profile

Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a biotechnology company. The Company is engaged in the medical device industry with its pioneering three dimensional (3D)-printed Sr-HT and Sr-HT-Gahnite orthopedic devices. It holds exclusive ownership of bio ceramic material, along with registered patents and patent applications from the University of Sydney. This material has several applications, including its use as a cervical fusion cage in spinal surgery, offering treatment options for patients. The Company is developing Sr-HT ceramic material to demonstrate the bioactivity required for bone regeneration. Sr-HT-Gahnite features bioactivity, biocompatibility, and mechanical properties suitable for load- bearing orthopedic implants. The primary focus centers on commercializing the Sr-HT Gahnite Bone substitute.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-29 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ALLEGRA MEDICAL TECHNOLOGIES LIMITED	-35.56%	2.26M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution